Prevention of Myocardial Infarction and Stroke by Aspirin: Different Mechanisms? Different Dosage?
- 15 September 1998
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 92 (1) , S7-S12
- https://doi.org/10.1016/s0049-3848(98)00101-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antiplatelet drugs and generation of thrombin in clotting bloodBlood, 1992
- High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation.Circulation, 1992
- A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic StrokeNew England Journal of Medicine, 1991
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971